WBI Investments’s Utah Medical Products UTMD Stock Holding History

WBI Investments’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,360	Closed	-$260K	–	341
2018 Q2	$260K	Buy	+2,360	New	+$246K	0.01%	222

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

WBI Investments's UTMD Position: Q3 2018 in Review

WBI Investments sold out of Utah Medical Products (UTMD) in Q3 2018, closing a stake of 2,360 shares — an estimated $260K sold.

WBI Investments first reported a position in UTMD in Q2 2018 and held it in 1 quarter. The position peaked at $260K in Q2 2018. 90 funds tracked by Wall St. Rank hold UTMD as of Q3 2018.

WBI Investments reported no remaining Utah Medical Products position as of Q3 2018 after selling out during the quarter.
WBI Investments sold 2,360 Utah Medical Products shares in Q3 2018, an estimated $260K.
WBI Investments first reported a position in Utah Medical Products in Q2 2018 and held it in 1 quarter.
WBI Investments's Utah Medical Products position peaked at $260K in Q2 2018.
90 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2018.

Based on WBI Investments's 13F filing for Q3 2018, filed 31 Oct 2018.